Publication bias with cetirizine in atopic dermatitis: Safe but ineffective? [6]

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 5, 2002, Pages 818-

  Hrachovec, Jennifer ^a   Warner, John O ^b  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; CORTICOSTEROID; HISTAMINE H1 RECEPTOR ANTAGONIST;

ATOPIC DERMATITIS; CHILDHOOD DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; PRIORITY JOURNAL; PRURITUS; PUBLICATION; SEDATION; SIDE EFFECT;

EID: 0036858534     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.128054     Document Type: Letter

References (5)

1. FER Simons Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child J Allergy Clin Immunol 104 2 Pt 1 1999 433 434
2. JO Warner A double- blind, randomized, placebo- controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up J Allergy Clin Immunol 108 2001 929 937
3. FER Simons Prevention of acute urticaria in young children with atopic dermatitis J Allergy Clin Immunol 107 2001 703 706
4. C Hoare A Li Wan Po H. Williams Systematic review of treatments of atopic eczema Health Technol Assess 4 2000 1 191
5. PA Klein RAF Clark An evidence-based review of the efficacy of antihistamines in relieving pruritis in atopic dermatitis Arch Dermatol 135 1999 1522 1525